EDOC


Telemedicine & Digital Health ETF

Fund Summary

The Global X Telemedicine & Digital Health ETF (EDOC) seeks to invest in companies positioned to benefit from further advances in the field of telemedicine and digital health. This includes companies involved in Telemedicine, Health Care Analytics, Connected Health Care Devices, and Administrative Digitization.

Fund Objective

The Global X Telemedicine & Digital Health ETF (EDOC) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Telemedicine & Digital Health Index.

Why EDOC?

High Growth Potential

EDOC enables investors to access high growth potential through companies at the leading edge of a structural trend affecting the global health care industry.

Unconstrained Approach

EDOC's composition transcends classic sector, industry, and geographic classifications by tracking an emerging theme.

ETF Efficiency

In a single trade, EDOC delivers access to dozens of companies with high exposure to the telemedicine & digital health theme.

Fund Details As of 04/15/21

Key Facts

Ticker EDOC
Inception Date 07/29/20
CUSIP 37954Y285
ISIN US37954Y2853
Bloomberg Index Ticker SOLEDOC
Primary Exchange Nasdaq
Number of Holdings 39

Stats & Fees

Net Assets $811,075,558
Net Asset Value (NAV) $19.99
Shares Outstanding 40,580,000
Total Expense Ratio 0.68%

Distributions

30-Day SEC Yield -0.40%
Distribution Frequency Semi-Annually

Fund Prices As of 04/15/21

NAV $19.99 Daily Change $0.23 1.15%
Market Price $20.07 Daily Change $0.25 1.26%
30-Day Median Bid-Ask Spread 0.16%

Performance History

As of recent month & quarter-end (03/31/21)
Fund NAV Market Price Index
Year-to-Date -0.93% -0.83% -0.82%
1 Month -5.16% -5.11% -5.11%
3 Months -0.93% -0.83% -0.82%
Since Inception 25.45% 25.58% 25.87%
Year-to-Date -0.93% -0.83% -0.82%
1 Month -5.16% -5.11% -5.11%
3 Months -0.93% -0.83% -0.82%
Since Inception 25.45% 25.58% 25.87%

Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance of the Fund, when observed, is unusual and investors should not expect such performance to be repeated.

Fund Characteristics As of 04/15/21

Return on Equity 14.10%
Weighted Avg. Market Cap 15,840 M
2020 2021
Price-to-earnings 80.68 68.42
Price-to-book value 10.29 9.05

Source: AltaVista Research, LLC

Sector Breakdown As of 03/31/21

% of Net Assets
Health Care 58.9
Information Technology 31.4
Industrials 3.7
Communication Services 3.6
Financials 1.4
Materials 1.0

Source: AltaVista Research, LLC

Country Breakdown As of 03/31/21

% of Net Assets
United States 84.0
Hong Kong 3.7
Japan 3.6
China 3.4
Netherlands 2.4
Germany 1.8
Australia 1.1

Source: AltaVista Research, LLC

Top Holdings As of 04/16/21

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
5.67 NUAN NUANCE COMMUNICATIONS INC 2402121 53.34 860,138 45,879,760.92
4.92 GH GUARDANT HEALTH INC BFXC911 158.50 250,988 39,781,598.00
4.54 A AGILENT TECHNOLOGIES INC 2520153 134.58 272,833 36,717,865.14
4.50 OMCL OMNICELL INC 2789523 137.84 263,893 36,375,011.12
4.45 PODD INSULET CORP B1XGNW4 297.00 121,363 36,044,811.00
4.42 ILMN ILLUMINA INC 2613990 399.00 89,549 35,730,051.00
4.41 LH LABORATORY CP 2586122 262.20 135,968 35,650,809.60
4.05 NEO NEOGENOMICS INC 2598246 49.34 664,501 32,786,479.34
4.04 CHNG CHANGE HEALTHCARE INC BK5CVS5 22.81 1,433,570 32,699,731.70
3.92 DXCM DEXCOM INC B0796X4 400.04 79,387 31,757,975.48
3.89 2413 JP M3 INC B02K2M3 77.20 408,109 31,504,072.05
3.65 CERN CERNER CORP 2185284 75.31 392,485 29,558,045.35
3.57 241 HK ALIBABA HEALTH BRXVS60 2.86 10,087,300 28,885,954.86
3.30 PINC PREMIER INC-CLASS A BDZDRC5 35.18 758,414 26,681,004.52
3.26 VEEV VEEVA SYSTEMS INC-CLASS A BFH3N85 273.07 96,502 26,351,801.14
3.23 1833 HK PING AN HEALTHCA BDRYVB3 12.27 2,129,400 26,117,519.42
2.92 NVTA INVITAE CORP BVVCNT1 37.64 627,165 23,606,490.60
2.87 TDOC TELADOC HEALTH INC BYQRFY1 190.10 122,184 23,227,178.40
2.81 TNDM TANDEM DIABETES CARE INC BF3W461 92.06 246,825 22,722,709.50
2.50 SAE GR SHOP APOTHEKE EUROPE NV BYYH7G9 236.59 85,463 20,220,114.16
2.28 RCM R1 RCM INC BD8PMK1 25.83 715,126 18,471,704.58
2.09 ONEM 1LIFE HEALTHCARE INC BKMG1N5 41.81 403,918 16,887,811.58
2.04 VCYT VERACYTE INC BFTWZY0 48.17 342,984 16,521,539.28
1.94 MDRX ALLSCRIPTS HEALT 2710039 15.72 996,273 15,661,411.56
1.84 COP GR COMPUGROUP MEDIC BMY7CH1 89.31 166,970 14,911,607.53
1.70 INOV INOVALON HOLDINGS INC - A BVV9XH0 29.78 462,415 13,770,718.70
1.40 IRTC IRHYTHM TECHNOLOGIES INC BYT4ST5 90.94 124,793 11,348,675.42
1.32 EHTH EHEALTH INC B1G0F83 70.15 152,565 10,702,434.75
1.32 EVH EVOLENT HEALTH INC - A BYLY8H1 20.16 528,678 10,658,148.48
1.23 PHR PHREESIA INC BKF9DQ8 51.10 195,427 9,986,319.70
1.21 PME AU PRO MEDICUS LTD 6292782 36.19 270,621 9,794,170.05
1.02 CDXS CODEXIS INC B5LL2C2 23.60 349,412 8,246,123.20
0.79 NXGN NEXTGEN HEALTHCARE INC BF5L3D6 18.75 339,305 6,361,968.75
0.71 TRHC TABULA RASA HEAL BYQBFS7 44.03 130,759 5,757,318.77
0.66 OPRX OPTIMIZERX CORP BF5MM09 51.61 103,289 5,330,745.29
0.59 SDC SMILEDIRECTCLUB INC BKT6B38 10.15 466,632 4,736,314.80
0.38 PSNL PERSONALIS INC BJQ0608 22.19 138,797 3,079,905.43
0.32 CPSI COMPUTER PROGRAM 2872122 30.87 84,425 2,606,199.75
0.18 OTRK ONTRAK INC BMVM5X6 31.78 45,532 1,447,006.96
0.08 CASH 1.00 669,118 669,116.61
Holdings are subject to change.


Investing involves risk, including the possible loss of principal. The investable universe of
companies in which EDOC may invest may be limited. The Fund invests in securities of companies engaged in the Health Care and Information Technology sectors. These sectors can be affected by government regulations, rapid product obsolescence, intense industry competition and loss or impairment of patents or intellectual property rights. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. EDOC is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Solactive AG, nor does Solactive AG make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Solactive AG.